This content is machine translated Therapy for initial diagnosis of multiple myeloma Treatment protocols in the age of modern substances We are in the era of new efficient compounds against multiple myeloma. Nevertheless, high-dose chemotherapy followed by autologous stem cell transplantation remains an essential part of the first-line treatment of…
View Post 6 min This content is machine translated Oncology Annual Congress in Basel Risk- and age-adapted approach to multiple myeloma In October, the annual congress of the German, Austrian and Swiss Societies of Hematology and Medical Oncology was held in Basel. A scientific symposium focused on risk- and age-adapted management…
View Post 4 min This content is machine translated Multiple Myeloma Active ingredients at a glance At the EHA Congress in Milan, multiple myeloma was the focus of several events. What are the current results of proteasome inhibitors and immunomodulatory drugs and what is their promise…
View Post 4 min This content is machine translated Non-Hodgkin's Lymphoma Bortezomib in previously untreated multiple myeloma. A subanalysis of the VISTA trial was presented at the ASH Congress in New Orleans, showing that a higher cumulative dose of bortezomib resulted in a better outcome in patients…
View Post 3 min This content is machine translated Non-Hodgkin's Lymphoma Pomalidomide in high-risk patients. Because data on the efficacy of pomalidomide in high-risk relapsed/refractory multiple myeloma populations are sparse, a phase II study set out to evaluate the agent in patients with GEP70 or…